Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Trial to Assess the Efficacy of Low Radiation Dose of 20 Gy for the Treatment of Marginal Zone Lymphoma or Follicular Lymphoma Stage I-II Localized in the Stomach or the Duodenum

NCT04097067 is registered in ClinicalTrials.gov with University Hospital Muenster as lead sponsor.

NCT NCT04097067
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04097067 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Trial to Assess the Efficacy of Low Radiation Dose of 20 Gy for the Treatment of Marginal Zone Lymphoma or Follicular Lymphoma Stage I-II Localized in the Stomach or the Duodenum
Lead sponsor
University Hospital Muenster
Phase
Not applicable
Overall status
Recruiting
Start date
September 1, 2019
Completion date
August 31, 2025
Enrollment
83 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

follicular lymphoma (gastric or duodenal), marginal zone lymphoma (gastric or duodenal)